Sqi Diagnostics Stock Fundamentals
SQIDFDelisted Stock | USD 0.01 0.00 0.00% |
SQI Diagnostics fundamentals help investors to digest information that contributes to SQI Diagnostics' financial success or failures. It also enables traders to predict the movement of SQI Pink Sheet. The fundamental analysis module provides a way to measure SQI Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SQI Diagnostics pink sheet.
SQI |
SQI Diagnostics Company Return On Equity Analysis
SQI Diagnostics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current SQI Diagnostics Return On Equity | -12.54 |
Most of SQI Diagnostics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SQI Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, SQI Diagnostics has a Return On Equity of -12.5407. This is 47.68% lower than that of the Health Care Equipment & Supplies sector and 87.74% higher than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
SQI Diagnostics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining SQI Diagnostics's current stock value. Our valuation model uses many indicators to compare SQI Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SQI Diagnostics competition to find correlations between indicators driving SQI Diagnostics's intrinsic value. More Info.SQI Diagnostics is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SQI Diagnostics' earnings, one of the primary drivers of an investment's value.SQI Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SQI Diagnostics' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of SQI Diagnostics could also be used in its relative valuation, which is a method of valuing SQI Diagnostics by comparing valuation metrics of similar companies.SQI Diagnostics is currently under evaluation in return on equity category among its peers.
SQI Fundamentals
Return On Equity | -12.54 | |||
Return On Asset | -0.94 | |||
Profit Margin | (2.29) % | |||
Operating Margin | (1.71) % | |||
Current Valuation | 34.24 M | |||
Shares Outstanding | 406.25 M | |||
Shares Owned By Insiders | 51.02 % | |||
Shares Owned By Institutions | 24.31 % | |||
Price To Earning | (2.35) X | |||
Price To Book | 16.12 X | |||
Price To Sales | 3.91 X | |||
Revenue | 8.1 M | |||
Gross Profit | 3.1 M | |||
EBITDA | (12.12 M) | |||
Net Income | (18.52 M) | |||
Cash And Equivalents | 3.96 M | |||
Cash Per Share | 0.01 X | |||
Total Debt | 6.3 M | |||
Debt To Equity | 4.64 % | |||
Current Ratio | 0.59 X | |||
Book Value Per Share | (0.03) X | |||
Cash Flow From Operations | (9.82 M) | |||
Earnings Per Share | (0.02) X | |||
Number Of Employees | 21 | |||
Beta | -0.0648 | |||
Market Capitalization | 34.43 M | |||
Total Asset | 9.31 M | |||
Retained Earnings | (55.6 M) | |||
Working Capital | 1.09 M | |||
Current Asset | 1.67 M | |||
Current Liabilities | 584 K | |||
Z Score | -7.3 | |||
Net Asset | 9.31 M |
About SQI Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SQI Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SQI Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SQI Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. SQI Diagnostics Inc. was founded in 1999 and is headquartered in Toronto, Canada. Sqi Diagnostics is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in SQI Pink Sheet
If you are still planning to invest in SQI Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SQI Diagnostics' history and understand the potential risks before investing.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |